Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

• Alessio Cirillo,
• Daniele Marinelli,
• Umberto Romeo,
• Daniela Messineo,
• Francesca De Felice,
• Marco De Vincentiis,
• Valentino Valentini,
• Silvia Mezi,
• Filippo Valentini,
• Luca Vivona,
• Antonella Chiavassa,
• Bruna Cerbelli,
• Daniele Santini,
• Paolo Bossi,
• Antonella Polimeni,
• Paolo Marchetti,
• Andrea Botticelli

Affiliations

Alessio Cirillo

Department of Radiological, Oncological and Pathological Sciences, Sapienza University

Daniele Marinelli

Department of Experimental Medicine, Sapienza University

Umberto Romeo

Department of Oral Sciences and Maxillofacial Surgery, Sapienza University

Daniela Messineo

Department of Radiological, Oncological and Pathological Sciences, Sapienza University

Francesca De Felice

Department of Radiological, Oncological and Pathological Sciences, Sapienza University

Marco De Vincentiis

Department of Sense Organs, Sapienza University

Valentino Valentini

Department of Oral Sciences and Maxillofacial Surgery, Sapienza University

Silvia Mezi

Department of Radiological, Oncological and Pathological Sciences, Sapienza University

Filippo Valentini

Department of Oral Sciences and Maxillofacial Surgery, Sapienza University

Luca Vivona

Department of Radiological, Oncological and Pathological Sciences, Sapienza University

Antonella Chiavassa

Department of Radiological, Oncological and Pathological Sciences, Sapienza University

Bruna Cerbelli

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University

Daniele Santini

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University

Paolo Bossi

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia

Antonella Polimeni

Department of Oral Sciences and Maxillofacial Surgery, Sapienza University

Paolo Marchetti

Istituto Dermopatico Dell’Immacolata (IDI-IRCCS)

Andrea Botticelli

Department of Radiological, Oncological and Pathological Sciences, Sapienza University